Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28710888 | 0.86 | MEN1 (0.50) | MEN1KMT2ANPSR1LMNAALDH1A1 | |
| SCHEMBL28980673 | 0.79 | MEN1 (0.41) | MEN1KMT2ANPSR1LMNAALDH1A1 | |
| SCHEMBL11941497 | 0.79 | MEN1 (0.46) | MEN1KMT2ANPSR1LMNAALDH1A1 | |
| SCHEMBL6005836 | 0.79 | CYP3A4 (0.48) | MEN1KMT2ANPSR1LMNACYP3A4 | |
| SCHEMBL10690351 | 0.79 | KMT2A (0.46) | MEN1KMT2ANPSR1LMNAALDH1A1 | |
| SCHEMBL11941449 | 0.79 | MEN1 (0.46) | MEN1KMT2ANPSR1LMNAALDH1A1 | |
| SCHEMBL28857096 | 0.77 | MEN1 (0.48) | MEN1KMT2ANPSR1LMNAALDH1A1 | |
| SCHEMBL6736653 | 0.74 | MEN1 (0.41) | MEN1KMT2ANPSR1LMNAALDH1A1 | |
| SCHEMBL13639011 | 0.74 | MEN1 (0.37) | MEN1KMT2ANPSR1LMNAALDH1A1 | |
| SCHEMBL18177631 | 0.74 | MEN1 (0.42) | MEN1KMT2ANPSR1LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107072187-A | Medicine volatilizer and medicament evaporation method | 大日本除虫菊株式会社 | 2017-08-18 | — | — | CN | disclosed |
| US-8518979-B2 | Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2013-08-27 | — | — | US | disclosed |
| US-20100152254-A1 | ALPHA-HALO- AND ALPHA-ALKYL-CYCLOPROPYLCARBOXY COMPOUNDS AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2010-06-17 | — | — | US | disclosed |
| EP-2114864-A1 | ALPHA-HALO- AND ALPHA-ALKYL-CYCLOPROPYLCARBOXY COMPOUNDS AND USES THEREOF | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (IL) | 2009-11-11 | — | — | EP | disclosed |
| WO-2008102348-A1 | ALPHA-HALO- AND ALPHA-ALKYL-CYCLOPROPYLCARBOXY COMPOUNDS AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2008-08-28 | — | — | WO | disclosed |
| EP-1262100-A1 | FAN TYPE CHEMICALS DIFFUSING DEVICE | Fumakilla Limited (JP) | 2002-12-04 | — | — | EP | disclosed |
| US-4151293-A | MITICIDES | ABBOTT LABORATORIES (US) | 1979-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152254-A1 | ALPHA-HALO- AND ALPHA-ALKYL-CYCLOPROPYLCARBOXY COMPOUNDS AND USES THEREOF | INA, GBA1, SCN1A | MEN1 1089/4885KMT2A 3744/4885NPSR1 859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.